BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2769002)

  • 21. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
    Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
    Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
    Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
    Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with locally advanced rectal adenocarcinoma treated with preoperative radiotherapy and surgery.
    Luna-Pérez P; Trejo-Valdivia B; Labastida S; García-Alvarado S; Rodríguez DF; Delgado S
    World J Surg; 1999 Oct; 23(10):1069-74; discussion 1075. PubMed ID: 10512949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
    Scott NA; Wieand HS; Moertel CG; Cha SS; Beart RW; Lieber MM
    Arch Surg; 1987 Dec; 122(12):1375-9. PubMed ID: 3689111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents.
    Angel CA; Pratt CB; Rao BN; Schell MJ; Parham DM; Lobe TE; Fleming ID
    Cancer; 1992 Mar; 69(6):1487-91. PubMed ID: 1311626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
    Lechner P; Lind P; Goldenberg DM
    J Am Coll Surg; 2000 Nov; 191(5):511-8. PubMed ID: 11085731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.
    Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I
    J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of the tumour markers CA 195 and CEA in patients with adenocarcinoma of the pancreas.
    Taylor OM; Cooper EH; Benson EA; McMahon MJ
    Eur J Surg Oncol; 1992 Oct; 18(5):508-13. PubMed ID: 1426303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
    Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
    Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols.
    Steele G; Ellenberg S; Ramming K; O'Connell M; Moertel C; Lessner H; Bruckner H; Horton J; Schein P; Zamcheck N; Novak J; Holyoke ED
    Ann Surg; 1982 Aug; 196(2):162-9. PubMed ID: 7046656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour markers in colorectal cancer.
    Roberts PJ
    Scand J Gastroenterol Suppl; 1988; 149():50-8. PubMed ID: 3201159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of recurrence of rectal cancer after potentially curative surgery.
    Rich T; Gunderson LL; Lew R; Galdibini JJ; Cohen AM; Donaldson G
    Cancer; 1983 Oct; 52(7):1317-29. PubMed ID: 6192900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor markers. II. Their significance in the follow-up of patients after radical resection of lung neoplasms].
    Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
    Minerva Chir; 1990 Oct; 45(20):1273-80. PubMed ID: 2082204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative clinical and pathological variables in prognostic evaluation of patients with rectal cancer. A prospective study of 327 consecutive patients.
    Ståhle E; Glimelius B; Bergström R; Påhlman L
    Acta Chir Scand; 1988 Mar; 154(3):231-9. PubMed ID: 3376681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
    Carpelan-Holmström MA; Haglund CH; Roberts PJ
    Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.
    Louhimo J; Kokkola A; Alfthan H; Stenman UH; Haglund C
    Int J Cancer; 2004 Oct; 111(6):929-33. PubMed ID: 15300805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
    Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
    Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.